Skip to main content

Comprehensive analysis of multi-omics single-cell

Comprehensive analysis of multi-omics single-cell data using the single-cell analyst


The rapid advancement of multi-omics single-cell technologies has significantly enhanced our ability to investigate complex biological systems at unprecedented resolution. However, many existing analysis tools are complex, requiring substantial coding expertize, which can be a barrier for computationally less competent researchers. To address this challenge, we present single-cell analyst, a user-friendly, web-based platform to facilitate comprehensive multi-omics analysis.

Single-cell analyst supports a wide range of data types, including six single-cell omics: single-cell RNA sequencing (scRNA-sequencing), single-cell assay for transposase accessible chromatin sequencing (scATAC-seq sequencing), single-cell immune profiling (scImmune profiling), single-cell copy number variation, cytometry by time-of-flight, and flow cytometry and spatial transcriptomics, and enables researchers to perform integrated analyses without requiring programming skills. The platform offers both online and offline modes, providing flexibility for various use cases. It automates critical analysis steps, such as quality control, data processing, and phenotype-specific analyses, while also offering interactive, publication-ready visualizations.

With over 20 interactive tools for intermediate analysis, single cell analyst simplifies workflows and significantly reduces the learning curve typically associated with similar platforms. This robust tool accommodates datasets of varying sizes, completing analyses within minutes to hours depending on the data volume, and ensures efficient use of computational resources. By democratizing the complex process of multi-omics analysis, single-cell analyst serves as an accessible, all-encompassing solution for researchers of diverse technical backgrounds. The platform is freely accessible at www.singlecellanalyst.org.

In our pursuit of fostering accessibility and efficiency in single-cell omics research, we developed single-cell analyst, a comprehensive multi-omics analytic platform that supports six single-cell omics types and spatial transcriptomics. The platform encapsulates popular single-cell omics workflows, providing a significant boon to researchers without a substantial computational background. By eliminating the need for dependency downloads and circumventing the complexities often associated with software installations, single-cell analyst addresses critical barriers to entry, enabling broader adoption of single-cell technologies.

Single cell analyst excels in its efficiency, user-friendliness, and broad scope, making it a formidable resource in the single-cell analysis landscape. By streamlining workflows, automating key steps, and offering interactive, publication-ready visualizations, it opens avenues for bench scientists to delve into multi-omics analysis, delivering advantages to a broad spectrum of the research community. Its coding-free design and integrative analysis capabilities lower the technical threshold, empowering researchers from diverse backgrounds to explore and interpret complex single-cell data with ease. The ability of the platform to analyses datasets across different omics fosters a systems-level understanding of biological phenomena, offering unprecedented flexibility for multi-omics analyses.

This capacity accelerates discovery processes and empowers researchers to generate insights into cellular heterogeneity, tissue architecture, and molecular mechanisms. By paving the way for innovative approaches to complex questions in biology and medicine, single-cell analyst not only drives the adoption of single-cell technologies but also broadens their application and facilitates interdisciplinary collaboration, representing a transformative advancement in the field of single-cell research.

single-cell RNA sequencing, transcriptomic profiling, cellular heterogeneity, scRNA-seq, gene expression analysis, cell type identification, single-cell genomics, microfluidics, droplet-based sequencing, spatial transcriptomics, cell lineage tracing, single-nucleus RNA-seq, multi-omics integration, epigenomics, immune cell profiling, tumor microenvironment, bioinformatics pipelines, trajectory analysis, high-throughput sequencing, data visualization

#SingleCell, #scRNAseq, #CellAtlas, #Transcriptomics, #SingleCellGenomics, #CellHeterogeneity, #SpatialTranscriptomics, #SingleCellAnalysis, #Bioinformatics, #Microfluidics, #CellLineage, #ImmuneProfiling, #TumorMicroenvironment, #SingleNucleusRNAseq, #MultiOmics, #Epigenomics, #TrajectoryInference, #GeneExpression, #HighThroughput, #DataVisualization


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...